What is it about?
This systematic review and meta-analysis evaluated the efficacy and safety of Embelia ribes and its active bio-marker, embelin and its derivatives in the treatment of diabetes mellitus.
Featured Image
Why is it important?
This systematic review and meta-analysis supports scientific evidence for the antidiabetic activity of Embelia ribes/embelin/derivatives of embelin.
Perspectives
Although this systematic review and meta-analysis supports scientific evidence for the antidiabetic activity of Embelia ribes/embelin/derivatives of embelin in experimental studies. However, further research is warranted in clinical trials to validate the present findings.
Mr Sharanbasappa Durg
Independent Institute
Read the Original
This page is a summary of: Antidiabetic activity of Embelia ribes, embelin and its derivatives: A systematic review and meta-analysis, Biomedicine & Pharmacotherapy, February 2017, Elsevier,
DOI: 10.1016/j.biopha.2016.12.001.
You can read the full text:
Resources
Contributors
The following have contributed to this page
